1 Choe PG, "Waning antibody responses in asymptomatic and symptomatic SARS-CoV-2 infection" 27 (27): 327-329, 2021
2 Lumley SF, "The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers" 2021
3 Pyoeng Gyun Choe, "Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea" 대한내과학회 35 (35): 765-770, 2020
4 Ibarrondo FJ, "Rapid decay of antiSARS-CoV-2 antibodies in persons with mild Covid-19" 383 (383): 1085-1087, 2020
5 Ripperger TJ, "Orthogonal SARSCoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity" 53 (53): 925.e4-933.e4, 2020
6 Dan JM, "Immunological memory to SARS-CoV-2assessed for up to 8 months after infection" 371 (371): eabf4063-, 2021
7 Wu LP, "Duration of antibody responses after severe acute respiratory syndrome" 13 (13): 1562-1564, 2007
8 Self WH, "Decline in SARSCoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network-12 states, April-August 2020" 69 (69): 1762-1766, 2020
9 Choe PG, "Antibody responses to SARS-CoV-2 at 8 weeks postinfection in asymptomatic patients" 26 (26): 2484-2487, 2020
10 Choe PG, "Antibody responses 8 months after asymptomatic or mild SARS-CoV-2 infection" 27 (27): 928-931, 2021
1 Choe PG, "Waning antibody responses in asymptomatic and symptomatic SARS-CoV-2 infection" 27 (27): 327-329, 2021
2 Lumley SF, "The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers" 2021
3 Pyoeng Gyun Choe, "Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea" 대한내과학회 35 (35): 765-770, 2020
4 Ibarrondo FJ, "Rapid decay of antiSARS-CoV-2 antibodies in persons with mild Covid-19" 383 (383): 1085-1087, 2020
5 Ripperger TJ, "Orthogonal SARSCoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity" 53 (53): 925.e4-933.e4, 2020
6 Dan JM, "Immunological memory to SARS-CoV-2assessed for up to 8 months after infection" 371 (371): eabf4063-, 2021
7 Wu LP, "Duration of antibody responses after severe acute respiratory syndrome" 13 (13): 1562-1564, 2007
8 Self WH, "Decline in SARSCoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network-12 states, April-August 2020" 69 (69): 1762-1766, 2020
9 Choe PG, "Antibody responses to SARS-CoV-2 at 8 weeks postinfection in asymptomatic patients" 26 (26): 2484-2487, 2020
10 Choe PG, "Antibody responses 8 months after asymptomatic or mild SARS-CoV-2 infection" 27 (27): 928-931, 2021